VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MGNX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MGNXMacroGenics, Inc.
$3.80$242M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMGNXQuarterly Financials

MacroGenics, Inc. (MGNX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

MacroGenics, Inc. (MGNX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

MGNX Income Statement

Quarterly statement

MGNX Income Statement

MacroGenics, Inc. (MGNX) annual income statement — 15-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue32.83M20.77M41.23M72.84M22.24M13.19M17.73M110.71M10.8M9.1M10.72M10.4M13.14M24.5M73.1M41.73M26.01M10.67M14.15M15.66M
Revenue Growth %47.62%57.48%132.53%-34.21%105.99%44.9%65.39%964.81%-17.81%-62.83%-85.34%-75.09%-49.49%129.51%416.71%166.47%-15.44%-36.78%-73.15%-10.07%
Cost of Goods Sold46.68M11.22M11.82M13.38M10.81M7.17M5.49M42.41M2.82M2.12M47.51M85K1.18M3.52M47.44M3.14M2.4M48K56.8M51.49M
COGS % of Revenue142.19%53.99%28.67%18.37%48.62%54.36%30.96%38.31%26.15%23.24%443.23%0.82%8.96%14.38%64.9%7.53%9.24%0.45%401.5%328.74%
Gross Profit-13.85M9.56M29.41M59.46M11.43M6.02M12.24M68.3M7.97M6.99M-36.79M10.31M11.96M20.97M25.66M38.59M23.61M10.63M-42.65M-35.83M
Gross Margin %-42.19%46.01%71.33%81.63%51.38%45.64%69.04%61.69%73.85%76.76%-343.23%99.18%91.04%85.62%35.1%92.47%90.76%99.55%-301.5%-228.74%
Gross Profit Growth %-221.21%58.74%140.25%-12.94%43.32%-13.84%133.27%562.29%-33.32%-66.68%-243.42%-73.28%-49.34%97.39%160.15%207.72%194.25%129.3%-510.48%-305.72%
Operating Expenses043M41.5M40.83M48.19M48.65M65.08M14.1M66.16M60.74M12.56M45.81M56.92M59.4M13.67M63.55M65.41M77.26M15.58M17.16M
OpEx % of Revenue-206.97%100.67%56.05%216.65%368.75%367.04%12.74%612.72%667.16%117.16%440.65%433.32%242.48%18.7%152.26%251.52%723.91%110.15%109.57%
Selling, General & Admin09.71M9.23M9.9M9.3M10.72M27.81M014.42M14.71M012.41M13.69M13.53M015.36M13.67M16.25M00
SG&A % of Revenue-46.74%22.4%13.6%41.82%81.25%156.85%-133.58%161.57%-119.35%104.23%55.22%-36.79%52.56%152.28%--
Research & Development033.29M32.27M30.92M38.88M37.93M38.89M40.54M51.73M46.03M47.35M30.13M43.23M45.87M45.65M48.19M51.74M61.44M55.85M49.82M
R&D % of Revenue-160.23%78.27%42.45%174.83%287.5%219.35%36.62%479.13%505.59%441.71%289.8%329.09%187.26%62.46%115.47%198.96%575.64%394.8%318.11%
Other Operating Expenses000000-1000K-1000K00-1000K1000K00-1000K00-428K-1000K-1000K
Operating Income-13.85M-33.44M-12.1M18.64M-36.76M-42.62M-52.84M54.19M-58.18M-53.75M-49.35M-35.5M-44.96M-38.43M11.98M-24.95M-41.81M-66.64M-58.24M-52.99M
Operating Margin %-42.19%-160.96%-29.34%25.59%-165.27%-323.1%-298.01%48.95%-538.86%-590.4%-460.39%-341.46%-342.28%-156.87%16.39%-59.8%-160.76%-624.36%-411.65%-338.32%
Operating Income Growth %62.32%21.55%77.11%-65.61%36.82%20.7%-7.06%252.64%-29.4%-39.88%-511.87%-42.26%-7.54%42.34%120.58%52.9%-3.8%-29.92%-2583.69%-46.64%
EBITDA-13.14M-31.75M-10.39M20.43M-34.85M-40.85M-50.78M56.03M-56.37M-51.91M-47.45M-33.55M-42.15M-35.44M15.21M-22.11M-38.93M-63.73M-55.28M-50.19M
EBITDA Margin %-40.03%-152.84%-25.21%28.04%-156.7%-309.68%-286.43%50.61%-522.09%-570.18%-442.67%-322.71%-320.87%-144.69%20.81%-52.98%-149.69%-597.07%-390.78%-320.46%
EBITDA Growth %62.29%22.28%79.54%-63.54%38.17%21.3%-7.02%266.98%-33.74%-46.46%-411.91%-51.74%-8.27%44.38%127.52%55.95%-3.82%-31.22%-7778.33%-51.3%
D&A (Non-Cash Add-back)708K1.69M1.71M1.79M1.91M1.77M2.05M1.83M1.81M1.84M1.9M1.95M2.81M2.98M3.23M2.84M2.88M2.91M2.95M2.8M
EBIT-65.25M-31.89M-10.66M20.16M-35.34M-40.95M-14.5M56.31M-55.66M-51.06M-46.07M17.55M58.24M-37.35M11.98M-24.81M-41.3M-66.44M-58.24M-52.99M
Net Interest Income-3.03M-3.33M-2.83M-1.81M612K1.59M2.09M2.12M2.52M1.56M3.28M3.06M1.5M417K1.7M142K504K195K00
Interest Income1.37M1.55M1.44M1.53M1.41M1.68M2.09M2.12M2.52M2.69M3.28M3.06M2.27M1.07M1.7M142K504K195K00
Interest Expense4.4M4.89M4.27M3.34M802K91K006K1.13M00774K656K000000
Other Income/Expense-55.79M-3.33M-2.83M-1.81M612K1.59M38.36M2.12M2.52M1.56M3.28M53.06M102.43M417K819K142K504K195K214K101K
Pretax Income-69.64M-36.77M-14.93M16.82M-36.15M-41.04M-14.48M56.31M-55.66M-52.19M-46.07M17.55M57.47M-38.01M12.8M-24.81M-41.3M-66.44M-58.02M-52.89M
Pretax Margin %-212.12%-177.01%-36.22%23.09%-162.52%-311.07%-81.65%50.86%-515.55%-573.26%-429.78%168.84%437.49%-155.16%17.51%-59.46%-158.82%-622.53%-410.14%-337.67%
Income Tax-89.16M0-777K0105K0944K0000000000000
Effective Tax Rate %128.02%0%5.2%0%-0.29%0%-6.52%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income19.52M-36.77M-14.15M16.82M-36.25M-41.04M-15.42M56.31M-55.66M-52.19M-46.07M17.55M57.47M-38.01M12.8M-24.81M-41.3M-66.25M-58.02M-52.89M
Net Margin %59.44%-177.01%-34.33%23.09%-162.99%-311.07%-86.98%50.86%-515.55%-573.26%-429.78%168.84%437.49%-155.16%17.51%-59.46%-158.82%-620.71%-410.14%-337.67%
Net Income Growth %153.83%10.39%8.21%-70.13%34.88%21.37%66.53%220.78%-196.86%-37.31%-459.88%170.75%239.14%42.63%122.06%53.08%-3.43%-29.21%-2680.16%-46.73%
Net Income (Continuing)19.52M-36.77M-14.15M16.82M-36.25M-41.04M-15.42M56.31M-55.66M-52.19M-46.07M17.55M57.47M-38.01M12.8M-24.81M-41.3M-66.44M-58.02M-52.89M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.31-0.58-0.220.27-0.57-0.65-0.250.90-0.89-0.84-0.740.280.92-0.620.21-0.40-0.67-1.08-0.95-0.86
EPS Growth %154.39%10.77%12%-70%35.96%22.62%66.22%221.43%-196.74%-35.48%-452.38%170%237.31%42.59%122.11%53.49%-1.52%-20%-2380.42%-30.3%
EPS (Basic)0.31-0.58-0.220.27-0.57-0.65-0.250.90-0.89-0.84-0.740.280.93-0.620.21-0.40-0.67-1.08-0.95-0.86
Diluted Shares Outstanding63.59M63.45M63.16M63.28M63.14M62.97M62.62M62.87M62.66M62.29M62.07M62.24M62.26M61.81M61.43M61.46M61.38M61.32M61.17M61.17M
Basic Shares Outstanding63.59M63.45M63.16M63.23M63.14M62.97M62.62M62.74M62.66M62.29M62.07M61.98M61.88M61.81M61.43M61.46M61.38M61.32M61.17M61.17M
Dividend Payout Ratio--------------------